Stephen DeCherney was CEO of Health Decisions, Inc. and is now a member of its board of directors. DeCherney was president of Clinical Development Services, North America at Quintiles Transnational Corporation. Through a series of four promotions, he became president of Global Clinical Research which comprised three business units:  Global Clinical Development Services, Global Data Management, and Global Drug Safety/Strategic Research Services. DeCherney’s P&L responsibility in these divisions amounted to approximately $1.25 BN in revenues annually. In his last role as chief innovation officer, he was responsible for designing a completely new approach to design and conduct of clinical trials for the pharmaceutical industry. DeCherney retired from Quintiles Transnational Corporation to return to academia.

DeCherney was elected to the board of directors of the RFK Center for Human Rights and Justice. He also serves as chair of the University of Delaware Research Foundation, a trustee of the Christiana Care Health System, Delaware, and as only one of two American Senior Advisors of the London School of Hygiene and Tropical Medicine, University of London, England. He was an independent director of Theorem Clinical Research Company, in which he sat on the Audit Committee. From 2008-2010, he was a member of the board of Symyx Corporation as an independent director, also serving on their Audit Committee.  In October 2008, DeCherney was elected as a trustee of the William Harvey Research Institute, of the Queen Mary Medical College, St. Barts and the London Hospitals, University of London. He was a senior advisor to the London Genetics Company, London, UK. He was also a member of the Farmer Food Share Board of Trustees and Chairman of their Finance Subcommittee.

A research physician, board certified in Internal Medicine and Endocrinology/Diabetes/Metabolism, named to the Best Doctors in America, DeCherney's research background includes four and a half years at the National Institutes of Health (NIH), followed by eleven years in various management roles in the Christiana Care Health System in Wilmington, Delaware. While there, he was the principal investigator for more than 100 clinical trials. During the same period, he also served as an Associate Professor at both the University of Delaware and Thomas Jefferson University. DeCherney left Christiana Care Health System to become executive vice president of Global Clinical Operations at PRA International (2000-04), where he remained until joining Quintiles.

He received his medical degree from Temple University in Philadelphia, and completed his internal medicine residency at the Graduate Hospital of the University of Pennsylvania. DeCherney received his endocrinology training at Vanderbilt University.  He also earned an MPH, Healthcare Policy and Management, from Columbia University School of Public Health.